Key facts
- iPill’s last known valuation is $10.5M (Apr 2025).
- It has raised $4.6M; the latest was Seed Round ($4.5M) in Apr 2025.
- Notable investors include Startupbootcamp Holding, Hunt Companies, Fischli Venture, Hartford InsurTech Hub, OCA Ventures — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for iPill
- ·The full record, as it builds
Funding rounds
No funding rounds for iPill are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About iPill
Developer of a secure medication dispenser intended to help remove barriers to Suboxone Opioid Use Disorder (OUD) therapy by offering safe, effective, at-home treatment. The company's device addresses the opioid crisis that predominantly impacts low-income communities by destroying unused medication, controlled dispensing, and medication adherence tracking by creating a tamper-proof home dispenser for opioids, enabling healthcare systems to take steps towards addressing unequal prescribing practices and standardizing care.
- Sector
- Healthcare
- HQ
- Los Angeles, CA, United States
- Founded
- 2017
- Employees
- 9
- Website
- ipill.tech/
- Ownership
- Privately Held (backing)
iPill doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in iPill shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on iPill in its N-PORT filings yet. We sweep new filings monthly.